Description

Cagrilintide – Dual Amylin and Calcitonin Receptor Agonist Reference Material

Cagrilintide is a long-acting, non-acylated synthetic peptide analogue of amylin that functions as a potent dual amylin and calcitonin receptor agonist (DACRA). It is widely investigated in preclinical and advanced laboratory models for its role in metabolic control, delayed gastric emptying, homeostatic appetite regulation, and glucose metabolism. Researchers frequently evaluate Cagrilintide both independently and in co-formulation studies to examine its synergistic effects on metabolic pathway modulation and energy balance.

Research-Only Use This material is strictly intended for laboratory research and laboratory analytical purposes only. It is not intended for human consumption, clinical diagnostic procedures, or veterinary administration. No claims are made regarding its safety, efficacy, or therapeutic applicability.

Disclaimer The information provided is curated strictly for scientific education and research reference. It is not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated or approved by the FDA or any equivalent regulatory agency.

Terms of Sale By purchasing this item, you confirm that you are a qualified researcher, institution, or laboratory operating in full compliance with all applicable local, state, and federal regulations. The seller assumes no liability for misuse, improper handling, unauthorized application, or unlawful distribution, and shall not be responsible for any resulting loss, injury, claim, or damage.